Policy Experts Forecast Potential Trump Admin Sympathy For Generics

AMELIA ISLAND, FL -- The next months of the new Trump administration could bring opportunities for generic drug manufacturers, pharmacy benefit manager reform, possible tweaks to Medicare drug negotiation and potentially major cuts to Medicaid, according to health policy experts who spoke at the Association for Accessible Medicines conference this week. Experts predicted the push for generics could translate to FDA regulatory reforms or potentially preferred formulary placement. One expert predicted CMS might use international benchmarking to drive down negotiated...